Clinical issues surrounding once-daily aminoglycoside dosing in children (Q35043373)

6 August 2017

title

Clinical issues surrounding once-daily aminoglycoside dosing in children (English)

1 reference

6 August 2017

Chad A Knoderer

1

1 reference

6 August 2017

Julie A Everett

series ordinal

2

1 reference

6 August 2017

William F Buss

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

23

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

44-56

1 reference

A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Once-daily dosing of aminoglycosides: review and recommendations for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

A prospective randomized study comparing once- versus twice-daily amikacin dosing in critically ill adult and paediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Once versus thrice daily gentamicin in patients with serious infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Pharmacodynamics of antibacterial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

The post-antibiotic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

In-vitro and in-vivo antimicrobial activities of a novel cephalosporin derivative, CP6162, possessing a dihydroxypyridone moiety at the C-3 side chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Pharmacokinetic analysis of amikacin twice and single daily dosage in immunocompromised pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Pharmacokinetic Analysis of Gentamicin Thrice and Single Daily Dosage in Pediatric Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Once daily ceftriaxone and gentamicin for the treatment of febrile neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Once daily antibiotic regimen in paediatric oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Aminoglycoside-induced ototoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Netilmicin in the treatment of gram-negative bacteremia: single daily versus multiple daily dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

National survey of extended-interval aminoglycoside dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

The Pharmacodynamics of Aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

The inductive role of ionic binding in the bactericidal and postexposure effects of aminoglycoside antibiotics with implications for dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Biphasic, concentration-dependent and rate-limited, concentration-independent bacterial killing by an aminoglycoside antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

21 January 2018

Postantibiotic effects

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

In vivo postantibiotic effect in a thigh infection in neutropenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Once-daily dosing decreases renal accumulation of gentamicin and netilmicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Pharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Gentamicin once-daily versus thrice-daily in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Ciprofloxacin and plasmids in staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Activity of human extravascular temocillin concentrations simulated in an in-vitro kinetic model against beta-lactamase producing gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Pharmacokinetics of once-daily gentamicin dosing in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

The pharmacokinetics and toxicity of once-daily tobramycin therapy in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

Pharmacokinetics of single daily dose gentamicin in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.1.44.31924

10.1592/PHCO.23.1.44.31924

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference